MET and cancer: The HGF/c-Met (Hepatocyte Growth Factor/Hepatocyte Growth Factor Receptor) signaling pathway (Figure 6) is frequently reactivated by cancer cells during tumorigenesis, invasive growth, and metastatic progression [36].